Johnson And Johnson Vaccine
-
{
- All
- News
- Videos
-
US Limits Johnson & Johnson Covid Vaccine Use Over Rare Blood Clot Risk
- Friday May 6, 2022
- World News | Agence France-Presse
The US said Thursday only adults who "have personal concerns" about mRNA vaccines, access issues or medical reasons for refusing them may now receive the Johnson & Johnson Covid shot, which has been linked to a rare but serious clotting condition.
-
www.ndtv.com
-
Johnson & Johnson Forecasts $2.5 Billion In COVID-19 Vaccine Sales
- Wednesday July 21, 2021
- World News | Reuters
Johnson & Johnson on Wednesday forecast just $2.5 billion in 2021 sales of its COVID-19 vaccine, which has fallen way behind rival shots from Pfizer and Moderna as the company deals with vaccine production issues and safety concerns.
-
www.ndtv.com
-
US Looking At Joint Production Of Johnson And Johnson's In India
- Tuesday May 11, 2021
- India News | Press Trust of India
The US is looking at joint production of Johnson and Johnson's COVID-19 vaccine in India and ways to help manufacturers like the Serum Institute of India (SII) to boost production, Daniel B Smith, the Charge D'Affaires of the US embassy, said on Tues
-
www.ndtv.com
-
Johnson & Johnson Starts Human Trial For Its COVID-19 Vaccine Candidate
- Thursday July 30, 2020
- World News | Reuters
Johnson & Johnson on Thursday kicked off US human safety trials for its COVID-19 vaccine after releasing details of a study in monkeys that showed its best-performing vaccine candidate offered strong protection in a single dose.
-
www.ndtv.com
-
US Limits Johnson & Johnson Covid Vaccine Use Over Rare Blood Clot Risk
- Friday May 6, 2022
- World News | Agence France-Presse
The US said Thursday only adults who "have personal concerns" about mRNA vaccines, access issues or medical reasons for refusing them may now receive the Johnson & Johnson Covid shot, which has been linked to a rare but serious clotting condition.
-
www.ndtv.com
-
Johnson & Johnson Forecasts $2.5 Billion In COVID-19 Vaccine Sales
- Wednesday July 21, 2021
- World News | Reuters
Johnson & Johnson on Wednesday forecast just $2.5 billion in 2021 sales of its COVID-19 vaccine, which has fallen way behind rival shots from Pfizer and Moderna as the company deals with vaccine production issues and safety concerns.
-
www.ndtv.com
-
US Looking At Joint Production Of Johnson And Johnson's In India
- Tuesday May 11, 2021
- India News | Press Trust of India
The US is looking at joint production of Johnson and Johnson's COVID-19 vaccine in India and ways to help manufacturers like the Serum Institute of India (SII) to boost production, Daniel B Smith, the Charge D'Affaires of the US embassy, said on Tues
-
www.ndtv.com
-
Johnson & Johnson Starts Human Trial For Its COVID-19 Vaccine Candidate
- Thursday July 30, 2020
- World News | Reuters
Johnson & Johnson on Thursday kicked off US human safety trials for its COVID-19 vaccine after releasing details of a study in monkeys that showed its best-performing vaccine candidate offered strong protection in a single dose.
-
www.ndtv.com